AlloVir
AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.
3
Funding Rounds
$159.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| An* Le** | - | - | |
| He*** He**** | - | - | |
| Ma***** Br***** | - | - | - |
| Jo** Wi**** | - | - | |
| Ju** Ve** | - | - | linkedin instagram |
| Cl**** Ro**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma***** Br***** | - | - | - |
| Ju** Ve** | - | - | linkedin instagram |
| Da*** Ha**** | - | - | |
| An***** Ga***** | - | - | |
| Je***** Bo******* | - | - | |
| Sh*** To******* | - | - | - |
| Mo**** Jo************* | - | - | |
| Di*** Br****** | - | - | |
| Vi*** Si*** | - | - |
Industries
AlloVir is active in the following industries:
- Technology
- Immunotherapy
- Cell therapy
- Therapeutics
- Biomedical engineering
- Biology
- Biotechnology
- Healthcare
- Regenerative medicine
- Tissue engineering
- Engineering
- Autoimmune disease
- Allogeneic cell therapy